Philip Stevens
Executive Director
Geneva Network
Philip founded Geneva Network in 2015.
His main research interests are the intersection of intellectual property, trade, and health policy. Formerly he was an official at the World Intellectual Property Organization (WIPO) in Geneva, where he worked in its Global Challenges Division on a range of IP and health issues.
Prior to his time with WIPO, Philip worked as director of policy for International Policy Network, a UK-based think tank, as well as holding research positions with the Adam Smith Institute and Reform, both in London. He has also worked as a political risk consultant and a management consultant.
He is a regular columnist in a wide range of international newspapers and has published a number of academic studies. He holds degrees from the London School of Economics and Durham University (UK).
He is also a Senior Fellow at the Institute for Democracy and Economic Affairs, Malaysia.
Recent Publications
Building a Global Framework for Digital Health Services in the Era of COVID-19
Health data and digital technologies will be essential for improving health outcomes across the globe beyond the COVID-19 pandemic. Low- and middle-income nations, with fledgling digital health strategies and many barriers to overcome, stand to benefit the most.
Severing the Link Between IP and Biomedical Innovation Isn’t the Answer to Global Health Care Challenges
Delinking the cost of R&D from the final prices of medicines and making governments the funders and planners of drug development would be rife with problems.
Delinkage Debunked: Why Replacing Patents With Prizes for Drug Development Won’t Work
Separating the cost of biopharmaceutical research and development from the final market price of medicines would misalign incentives, raise bureaucratic costs, and limit innovation.
Innovate4Health Latin America: How Innovators Are Solving Global Health Challenges
Seven case studies showcase how IP rights are enabling innovators in Latin America to help solve some of the greatest global health challenges.
Trump Should Seek Rules to Protect Intellectual Property in the Modern Era
The Trump administration’s trade strategy has largely taken aim at unfair trade practices in traditional industries. Yet, as Philip Stevens and Nigel Cory explain in The Hill, foreign actors are threatening another major component of the U.S. economy that we hear much less about: the theft of knowledge and IP in a wide variety of traditional and high-tech sectors.
Recent Events and Presentations
2021 Global Trade and Innovation Policy Alliance Annual Summit
The GTIPA’s annual summits bring together alliance members with world-leading experts to explore creative solutions to the difficult economic, trade, and innovation challenges facing the international community.
The Role of Intellectual Property Rights in Ending the COVID-19 Pandemic
ITIF and Geneva Network hosted a discussion on the role of IP rights in vaccine and therapeutic R&D, manufacturing, and preparedness for future pandemics. Panelists from around the world will discuss the best ways to scale up mass vaccine and therapeutic manufacturing and examine the implications that would arise from a global waiver of IP rights.
